-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on Immunome, Lowers Price Target to $23

Benzinga·11/10/2026 14:42:06
Listen to the news
Stifel analyst Dara Azar maintains Immunome (NASDAQ:IMNM) with a Hold and lowers the price target from $24 to $23.